Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Zhao M, Song L, Sun L, Wang M, Wang C, Yao S, Li Y, Yun C, Zhang S, Sun Y, et al. Associations of type 2 diabetes onset age with cardiovascular disease and mortality: the Kailuan Study. Diabetes Care. 2021;44(6):1426–32.

Article  PubMed  PubMed Central  Google Scholar 

Liu W, Zhang D, Wang R, Chen J, Zhang J, Tao D, Liu C. Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: an age-period-cohort analysis. Diabetes Obes Metab. 2023.

Igweokpala S, Sule NO, Douros A, Yu OHY, Filion KB. Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Obes Metab; 2023.

Barbiellini Amidei C, Fayosse A, Dumurgier J, Machado-Fragua MD, Tabak AG, van Sloten T, Kivimaki M, Dugravot A, Sabia S, Singh-Manoux A. Association between age at diabetes onset and subsequent risk of dementia. JAMA. 2021;325(16):1640–9.

Article  PubMed  PubMed Central  Google Scholar 

Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanonidou C. Small dense low-density lipoprotein: analytical review. Clin Chim Acta. 2021;520:172–8.

Article  CAS  PubMed  Google Scholar 

Goodpaster BH, Kelley DE. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep. 2002;2(3):216–22.

Article  PubMed  Google Scholar 

Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007;117(3):746–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haase CL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. HDL cholesterol and risk of type 2 diabetes: a mendelian randomization study. Diabetes. 2015;64(9):3328–33.

Article  CAS  PubMed  Google Scholar 

Fritzen AM, Domingo-Espin J, Lundsgaard AM, Kleinert M, Israelsen I, Carl CS, Nicolaisen TS, Kjobsted R, Jeppesen JF, Wojtaszewski JFP, et al. ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKalpha(2). Mol Metab. 2020;35:100949.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119(15):2103–11.

Article  CAS  PubMed  Google Scholar 

Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130–8.

Article  CAS  PubMed  Google Scholar 

Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127.

Article  PubMed  PubMed Central  Google Scholar 

Steiner G, Vranic M. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Int J Obes. 1982;6(Suppl 1):117–24.

CAS  PubMed  Google Scholar 

Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–8.

Article  CAS  PubMed  Google Scholar 

Okan T, Doruk M, Ozturk A, Topaloglu C, Dogdus M, Yilmaz MB. Evaluation of plasma atherogenic index, triglyceride-glucose index and other lipid ratios as predictive biomarkers of coronary artery disease in different age groups. Diagnostics (Basel) 2024, 14(14).

Ma L, Sun F, Zhu K, Han Q, Sun Q. The predictive value of Atherogenic Index of Plasma, non- high density lipoprotein cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and lipoprotein combine Index for Stroke incidence and prognosis in maintenance hemodialysis patients. Clin Interv Aging. 2024;19:1235–45.

Article  PubMed  PubMed Central  Google Scholar 

Yan H, Zhou Q, Wang Y, Tu Y, Zhao Y, Yu J, Chen K, Hu Y, Zhou Q, Zhang W, et al. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2024;23(1):142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Babaahmadi-Rezaei H, Raeisizadeh M, Zarezade V, Noemani K, Mashkournia A, Ghaderi-Zefrehi H. Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS). Diabetol Metab Syndr. 2024;16(1):112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Althwab SA, Abdulmonem WA, Allemailem KS, Alarifi SA, Hamad EM. Prediction of cardiovascular risk factors and metabolic syndrome in adults from Saudi Arabia using the logarithm of triglyceride/HDL-cholesterol ratio. Int J Health Sci (Qassim). 2024;18(2):50–5.

PubMed  Google Scholar 

Zhang H, Zhang G, Fu J. Exploring the L-shaped relationship between Atherogenic Index of plasma and depression: results from NHANES 2005–2018. J Affect Disord. 2024;359:133–9.

Article  CAS  PubMed  Google Scholar 

Chen T, Qian Y, Deng X. Relationship between atherosclerotic burden and depressive symptoms in hypertensive patients: a cross-sectional study based on the NHANES database. J Affect Disord. 2024;361:612–9.

Article  CAS  PubMed  Google Scholar 

You FF, Gao J, Gao YN, Li ZH, Shen D, Zhong WF, Yang J, Wang XM, Song WQ, Yan H, et al. Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population–based cohort study. Cardiovasc Diabetol. 2024;23(1):276.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng X, Zhang X, Han Y, Hu H, Cao C. Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol. 2023;22(1):205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu XW, Deng FY, Lei SF. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9(1):60–7.

Article  PubMed  Google Scholar 

Yang S, Gou X, Dong H, Chen L, Wang Y, Wu J. Physical activity modifies the association between atherogenic index of plasma and prediabetes and diabetes: a cross-sectional analysis. J Diabetes. 2024;16(10):e70006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Y, Li F, Zhou Y, Liu A, Lin X, Zou Z, Lv X, Zhou J, Li Z, Wu X, et al. Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data. Cardiovasc Diabetol. 2024;23(1):226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang L, Li L, Xu Z, Tang Y, Zhai Y, Fu X, Liu D, Wu Q. Non-linear associations of atherogenic index of plasma with prediabetes and type 2 diabetes mellitus among Chinese adults aged 45 years and above: a cross-sectional study from CHARLS. Front Endocrinol (Lausanne). 2024;15:1360874.

Article  PubMed  Google Scholar 

Yi Q, Ren Z, Bai G, Zhu S, Li S, Li C, Wu H, Zhu Y, Song P. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese. Acta Diabetol. 2022;59(2):269–79.

Article  CAS  PubMed  Google Scholar 

Yang H, Kuang M, Yang R, Xie G, Sheng G, Zou Y. Evaluation of the role of atherogenic index of plasma in the reversion from Prediabetes to